PTEN null prostate cancer cells have increased nuclear β-Catenin expression, TCF promoter activity and expression of the β-Catenin regulated gene Cyclin D1, which are suppressed upon re-expression of wild type PTEN[33], [34]. Here, PTEN is linked to prostate carcinoma.